Fast Melt Tablets Market
Fast Melt Tablets Market Share Analysis By Drug Class (Anti-Psychotics, Anti-Epileptics, CNS Stimulants, Anxiolytics), By Indication (CNS Diseases, GI Diseases, CVS Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region - Global Insights 2021 to 2031
Analysis of Fast Melt Tablets Market Covering 30 + Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Fast Melt Tablets Market Forecast and CAGR:
According to the latest research by Fact.MR, the fast melt tablets market is set to observer a growth of 9-10% during the forecast period. Demand for fast melt tablets expects to observer stable recovery in the short-term, with a positive growth position in the long run. High adoption of fast melt tablets technology will offer lucrative opportunities in near future.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the major drivers of the Fast Melt Tablets Market?
Fast melts tablet is an oral solid dosage form which disintegrates in the oral cavity without water or chewing. Fast or mouth dissolving tablets have been formulated for active patients who are busy in travelling, may not have access to water, patient who can’t swallow. It is highly adopted by pediatric, geriatric, and bedridden patients.
Because of various innovations in the field of oral-dissolving drug delivery system, they can now be used for numerous benefits such as rapid drug therapy intervention, increased bioavailability, good stability, easy manufacturing, unite and accurate dosing, easy handling, motion sickness, suede episodes of allergic attack or coughing, where an ultra-rapid onset of action required.
The increase in the elderly population, who cannot swallow medicine, the increase in product promotion aimed at raising awareness of the treatment of patients. Rise in demand for patient compliance and cost-effective products to improve the quality of patients’ lives.
Due to administration of oral solid traditional formulations there is a risk of chocking or suffocation. In addition, technological innovations in fast melt tablet who meet pharmacopeia requirement where tablet disperses rapidly before swallowing and which disintegrates in less than 3 minutes. This have further supplemented the market growth.
High Adoption of Fast Melt Tablets Expected To Boost the Demand
High adoption of fast-melt tablet by geriatric population give demand progress for fast melt tablets market during the forecast period. First pass metabolism is big issue in a conventional oral formulation that can be prevented with the help of fast melt tablet.
These drug delivery systems are capable of achieving patient compliance a great extent which boosts the demand. Self-administration is possible with high bioavailability and immediate action and decreased side effect of drug to patients. This are the formulation driving force for more adoption.
However, some technological challenges that may create hindrance in this drug delivery system can be the overcome with extensive research in formulation and development. This add on to more adoption of this fast-melt tablet.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
North America Fast Melt Tablets Demand Outlook
Due to the market player innovation, the North American market occupies an important part of the global demand.The major factors that makes the North American market largest revenue generating region in this field are the presence of major companies manufacturing the advance drug delivery system who are funding various R&D activities for the market. Along with the above mentioned factors, the increased disposable income and various developments in the healthcare industry are other key factors leading to market dominance.
Europe Fast Melt Tablets Demand Outlook
Europe being the second most dominating region in this field, due to high percentage of geriatric population. According to the research done by Eurostat in 2019, there were 90.4 Mn older people. Geriatric population is the adopting due to swallowing issues and gastrointestinal track is also week of old age patient so that adopt more fast melt tablet. Also, a rising incidence of heart attack in Europe so in such cases fast melt tablets act for rapid delivery and immediate action. This are some factors that can drive the market.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Who are the key players in the Fast Melt Tablets Market?
Some of the manufacturers of fast melt tablet are
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- AstraZeneca
- Mylan N.V.
- Pfizer Inc.
- Johnson & Johnson Services Inc.
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Bausch Health
- GlaxoSmithKline plc
- Sun Pharmaceutical Industries Ltd.
- Bayer AG
- Eli Lily and Company
- Dr. Reddy’s Laboratories Ltd.
- Takeda Pharmaceutical Company Limited
- Kissei Pharmaceutical Co.Ltd.
For instance in June 2019, Kissei Pharmaceutical Co., Ltd. launched GLUBES® which is the new orally disintegrating dosage form of GLUBES® Combination Tab.
Fast Melt Tablets Market Report Highlights:
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size recent industry trends
- Key Competition landscape
- Strategies for key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
Key Segments:
-
By Drug Class :
- Anti-Psychotics
- Anti-Epileptics
- CNS Stimulants
- Anxiolytics
- Anti-Parkinsonian Drugs
- Anti-Hypertensive
- NSAIDS
- Anti-Allergy Drugs
- Proton Pump Inhibitors
- Others
-
By Indication :
- CNS Diseases
- GI Diseases
- CVS Disorders
- Allergy
- Others
-
By Distribution channel :
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
-
By region :
- North America:
- Latin America
- Europe:
- East Asia:
- South Asia:
- Oceania:
- Middle East and Africa:
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Drug Class
- 6.2. Indication
- 6.3. Distribution Channel
- 7. Global Market Analysis and Forecast, By Drug Class
- 7.1. Anti-Psychotics
- 7.2. Anti-Epileptics
- 7.3. CNS Stimulants
- 7.4. Anxiolytics
- 7.5. Anti-Parkinsonian Drugs
- 7.6. Anti-Hypertensive
- 7.7. NSAIDS
- 7.8. Anti-Allergy Drugs
- 7.9. Proton Pump Inhibitors
- 7.10. Others
- 8. Global Market Analysis and Forecast, By Indication
- 8.1. CNS Diseases
- 8.2. GI Diseases
- 8.3. CVS Disorders
- 8.4. Allergy
- 8.5. Others
- 9. Global Market Analysis and Forecast, By Distribution Channel
- 9.1. Hospital Pharmacies
- 9.2. Retail Pharmacies
- 9.3. Drug Stores
- 9.4. Online Pharmacies
- 10. Global Market Analysis and Forecast, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. MEA
- 11. North America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 17. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 18. Sales Forecast by Drug Class, Indication, and Distribution Channel for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. Teva Pharmaceutical Industries Ltd.
- 20.2. Novartis AG
- 20.3. AstraZeneca
- 20.4. Mylan N.V.
- 20.5. Pfizer Inc.
- 20.6. Johnson & Johnson Services Inc.
- 20.7. F. Hoffmann-La Roche Ltd.
- 20.8. Merck & Co., Inc.
- 20.9. Bausch Health
- 20.10. GlaxoSmithKline plc
- 20.11. Sun Pharmaceutical Industries Ltd.
- 20.12. Bayer AG
- 20.13. Eli Lily and Company
- 20.14. Dr. Reddy’s Laboratories Ltd.
- 20.15. Takeda Pharmaceutical Company Limited
- 20.16. Kissei Pharmaceutical Co.Ltd.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Drug Class
Table 3: Global Market US$ Mn Forecast by Indication
Table 4: Global Market US$ Mn Forecast by Distribution Channel
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Drug Class
Table 7: North America Market US$ Mn Forecast by Indication
Table 8: North America Market US$ Mn Forecast by Distribution Channel
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Drug Class
Table 11: Latin America Market US$ Mn Forecast by Indication
Table 12: Latin America Market US$ Mn Forecast by Distribution Channel
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Drug Class
Table 15: Western Europe Market US$ Mn Forecast by Indication
Table 16: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Drug Class
Table 19: Eastern Europe Market US$ Mn Forecast by Indication
Table 20: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Drug Class
Table 23: East Asia Market US$ Mn Forecast by Indication
Table 24: East Asia Market US$ Mn Forecast by Distribution Channel
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Drug Class
Table 27: South Asia & Pacific Market US$ Mn Forecast by Indication
Table 28: South Asia & Pacific Market US$ Mn Forecast by Distribution Channel
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Drug Class
Table 31: MEA Market US$ Mn Forecast by Indication
Table 32: MEA Market US$ Mn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the growth outlook for the fast-melt tablets market by 2031?
According to Fact.MR, the fast melt tablets market is set to observe a growth of 9-10% during the forecast period.
What factors are driving the fast melt tablets market?
Inability to swallow tablets by patients, increased bioavailability, and adoption by pediatric patients are driving this market’s growth.
Which region dominates the fast melt tablets market by 2031?
North America dominates the fast melt tablets market in terms of revenue generation followed by Europe during the forecast period.
Fast Melt Tablets Market